The American Academy of Pain Medicine

AAPM 25th Annual Meeting Preconference Sessions

• Ultrasound Guided Blocks
• Intrathecal Therapies for Chronic Pain
• Opioids Preconference Session
• Register Now

Ultrasound Guided Blocks

Tuesday, January 27, 2009 
1:00pm - 5:00pm

Overview:

Responding to an accelerated interest in the use of ultrasound guided blocks in the treatment of pain medicine, this preconference session will provide an overview of the advantages as well as the limitations of this imaging modality in the practice of pain medicine. Expert faculty will engage with ultrasound novices to practice real time techniques for common ultrasound procedures including nerve, joint, and axial procedures. In addition to the hands on learning applications, attendees will have the opportunity to review literature regarding, feasibility, safety and patient outcomes.

Course Objectives:

At the completion of this course, attendees will be able to apply the diagnostic and interventional techniques of ultrasound technology, perform diagnostic musculoskeletal ultrasound examinations, and apply real time ultrasound visualization to guide the needle to the target joint safely and efficiently. Attendees will become proficient in adjusting machine settings to optimize images, demonstrate basic ultrasound exams, and visualize needles through the use of ultrasound technology.

Faculty Roster

Mark F. Hurdle, MD
Departments of Anesthesiology, Pain Medicine, and PM&R
Mayo Clinic
Rochester, MN

Hugh M. Smith, MD PhD
Department of Anesthesiology
Mayo Clinic
Rochester MN

Matthew J. Pingree, MD
Departments of Anesthesiology, Neurology, and PM&R
Mayo Clinic
Rochester, MN

Bryan C. Hoelzer, MD
Department of Anesthesiology
Mayo Clinic
Rochester, MN

Additional Faculty tbd

NOTE: Due to the ‘hands on' interactive format of this preconference session, space will be limited to 50 registrants.

Back to top

Intrathecal Therapies for Chronic Pain

Wednesday, January 28, 2009
6:00am - 7:15am

Intrathecal Therapies for Chronic Pain: Old Challenges and New Developments (112)

Overview:

Intrathecal drug delivery (IDD) for the management of intractable cancer and non-cancer pain has been available for nearly 30 years.  Advantages of IDD include effective pain control, fewer side effects compared with systemic medications, ability to easily adjust dosages, and provide a therapy that is reversible.  This course will provide a comprehensive overview of intrathecal therapy including pharmacologic sites of action, emerging  therapies including the most current consensus-based treatment algorithm, advances in medication delivery (equipment and programming), as well as potential complications arising from IDD and strategies to minimize their occurrence.

Program Schedule:

6:00 - 6:05 am
Moderator
Leonardo Kapural, MD, PhD

6:05 - 6:25 am
Novel Algorithm for Intrathecal Therapy: Rationale for Algorithm Changes
Timothy R. Deer, MD

6:25 - 6:45 am
Current Dilemmas and Future Challenges in Intrathecal Therapies: Opioids Versus Non - Opioids
Leonardo Kapural, MD, PhD

6:45 - 7:05 am
Complications of Intrathecal Therapies Including IT Granulomas
B. Todd Sitzman, MD, MPH

7:05 - 7:15 am
Question and Answer

This program is supported by an unrestricted educational grant from Elan Pharmaceuticals, Inc. 

Back to top

Opioids Preconference Session  

Wednesday, January 28, 2009
7:30am - 4:45pm

Opioid Therapy: Cutting Edge Scientific Approaches and Practical Strategies

Overview:

Healthcare professionals across the healthcare continuum work closely with patients who are experiencing various types and intensities of pain. Emerging advancements in pain management have given chronic pain patients and their families different types of treatment that allow a renewed dimension to the quality of their life. It is imperative that pain medicine clinicians keep up to date on emerging pain medicine assessment strategies, treatment options, and pharmacologic and non pharmacologic approaches to the treatment of chronic non cancer pain.

While advances in pharmacologic management of pain have led to improved clinical outcomes, heightened awareness of the misuse of prescription opioid medications is a critical clinical and public health concern that has significant impact on the healthcare delivery system.

 This full day preconference session will review the major public health concerns and examine the evidence of current epidemiology studies, while exploring the association between effective chronic non cancer pain treatment and opioid misuse. In addition to addressing the ongoing ethical, legal and regulatory implications, renowned faculty will unveil alternative and long term treatment strategies to meet the ongoing needs of patients with dependence and addictions disorders.

Learning objectives:

At the end of this full day session, participants will be able to:

• Review the science of prescription opioid misuse and addiction.
• Assess and manage risks related to potential opioid abuse, addiction and diversion.
• Incorporate ‘best practices' to optimize opioid use for the treatment of chronic pain.
• Identify pharmacologic mechanisms of opioids misuse and addiction.
• Recognize the challenges faced by the pain specialists in navigating the clinical and regulatory issues and identify opportunities to overcome these challenges in their day to day practice.
• Improve pain management by improving communication skills between clinician and patient.
• Summarize the APS- AAPM Chronic Opioid Therapy Guidelines.

Program Schedule:

Opioid Therapy: Cutting Edge Scientific Approaches and Practical Strategies (002)

Update on the Science of Prescription Opioid Misuse and Addiction 
Howard A. Heit, MD
Assistant Clinical Professor
Georgetown School of Medicine
Fairfax, VA

Use of Abuse Resistant Formulations and Buprenorphine in a Pain Practice
Michael H. Moskowitz, MD MPH
Bay Area Pain Medical Associates
Mill Valley, CA

Unappreciated Risks of Opioids--Endocrine Effects, Sleep-Disordered Breathing, and Hyperalgesia
Lynn R. Webster, MD
Medical Director
Lifetree Pain Clinic
Salt Lake City, UT

Recent Legal Controversies Surrounding Opioids
Edward Michna, JD MD
Department of Anesthesiology, Perioperative and Pain Medicine
Pain Management Center
Brigham and Women's Hospital
Chestnut Hill, MA

How to be a Helpful Consultant Without Having to Write for Opioids Indefinitely: The Trilateral Agreement
Ajay D. Wasan, MD MSc - Integrative Track Section Head
Anesthesiology and Psychiatry
Pain Management Center
Harvard Medical School/Brigham and Women's Hospital
Chestnut Hill, MA

Update on Methadone: Pitfalls, Toxicities, Drug-Drug Interactions and Use in a Patient-Controlled Analgesia Pump
Scott M. Fishman, MD
Chief - Division of Pain Medicine
Department of Anesthesiology and Pain Medicine
University of California Davis, School of Medicine
Lawrence J. Ellison Ambulatory Care Center
Sacramento, CA

How to Run a Nurse Practitioner or Physician Assistant Opioid Clinic
Rollin M. Gallagher, MD MPH
Director for Pain Policy Research and Primary Care
Penn Pain Medicine
Clinical Professor of Psychiatry and Anesthesiology
University of Pennsylvania School of Medicine
and
Director - Pain Medicine Service
Philadelphia Veterans Affairs Medical Center
Philadelphia, PA

APS-AAPM Chronic Opioid Therapy Guidelines
Perry G. Fine, MD - Program Committee Co-Chair
Professor of Anesthesiology
University of Utah - Pain Research Center
Department of Anesthesiology, School of Medicine
Salt Lake City, UT

REGISTER ONLINE

Download AAPM Physician Member Application

Back to top